Stay updated on Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer's site revision label updates from v3.7.1 to v3.7.2 while the page continues to display a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-19T00:16:47.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    The site footer’s revision label changes from v3.7.0 to v3.7.1. The study record remains inaccessible behind a 403 Forbidden page.
    Difference
    0.2%
    Check dated 2026-10-12T00:37:41.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    The study record page now shows a 403 Forbidden error, replacing the full study content with a minimal header/footer; this indicates the page is inaccessible, limiting visibility into the trial information and attachments.
    Difference
    18%
    Check dated 2026-09-20T22:57:08.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    The page now includes posted results with metrics such as Complete Response rate, Overall Response Rate, and 2-year Progression-Free Survival, along with the posting dates and a PDF of the Study Protocol and Statistical Analysis Plan. Older results-submission entries, including the complete response rate, have been removed.
    Difference
    2%
    Check dated 2026-09-06T22:26:18.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page shows a new revision label, updating from v3.6.5 to v3.6.6, indicating a minor update to the page version.
    Difference
    0.1%
    Check dated 2026-08-30T22:19:20.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    Page revision was updated from v3.6.4 to v3.6.5, signaling a software release or maintenance update to the ClinicalTrials.gov page. The update does not modify study details, eligibility criteria, or other content visible on the page.
    Difference
    0.1%
    Check dated 2026-08-09T11:04:30.000Z thumbnail image

Stay in the know with updates to Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab with Radiation in Hodgkin Lymphoma Clinical Trial page.